Aspire Infusions

Top states where Aspire Infusions is active based on indexed sales coverage.

ONOntario

($250-500K)

ABAlberta

(<$250K)

SKSaskatchewan

(<$250K)

MBManitoba

(<$250K)

NJNew Jersey

(<$250K)

WAWashington

(<$250K)

Trend narrative unavailable.

24-Month Trend

Oral products dominate, accounting for 85.4% of sales with a remarkable YoY increase of +20.1%. In contrast, Concentrates are declining sharply at -14.0% YoY, indicating shifting consumer preferences.

Category	Sales Share	Avg Price	YoY
Oral	85.4%	$30.52	20.1%
Edibles	9.2%	$26.9	8.5%
Concentrates	3.7%	$23.94	14.0%
Flower	1.7%	$29.96	3.4%

Top cannabis brands in Ontario lead the charge with 99.6% of ASPIRE INFUSIONS' sales. The brand also has a presence in Alberta and Saskatchewan, showcasing a concentrated geographic footprint across 6 states.

State	Concentrates	Edibles	Flower	Oral
Saskatchewan	⊖	⊖	⊖	17
Alberta	⊖	⊖	⊖	20
Manitoba	⊖	⊖	⊖	⊖
Ontario	⊖	36	⊖	5

#3 in Oral, trailing BHANG at #1 and REDECAN at #2. Competitive tension is palpable as ASPIRE INFUSIONS aims to close the gap on the leaders.

Top products for Feb 2026 with sales and momentum indicators.

Product	Category	MoM
#1 Cool Mint 1 Each Oral Tablet Tablet 25 Pack	Oral	N/A
#2 Spark Moonrocks [15pk] (150mg)	Oral	29.1%
#3 Caramel 1 Each Edibles Chocolate Bites 4 Pack	Edibles	6.6%
#4 Halo 1 Each Flower Flower (unspecified)	Flower	• 0.0%
#5 Caramel 10 Mg Edibles Chocolate Bites 4 Pack	Edibles	0.7%
#6 Sour Cherry 1 Each Edibles Soft Candy Gummies 25 Pack	Edibles	100.0%
#7 Cool Mint 1 Each Oral Oral (unspecified) Oral (unspecified) 25 Pack	Oral	• 0.0%
#8 Halo 1 Each Vapes Cartridges	Vapes	• 0.0%
#9 1 Each Accessories Vape Cartridge Devices	Accessories	25.2%

Peer brands benchmarked against Aspire Infusions using competitive landscape rank coverage, proximity, and momentum.

Redecan

UF

Ufeelu

Tweed

Bhang